Cardinal Health, Inc. hit a new 52-week high stock price of $62.15 but closed slightly lower at $61.90. While the company has registered a 1.7% stock gain over the past year and is witnessing an upward trend spurred by its diversified product portfolio, it lags significantly behind industry peers. Financially, Cardinal only registered a 2.2% earnings gain over five years, contrasted with the industry's 12.8%. The company's heavy reliance on CVS Caremark for over 20% of revenue underscores vulnerabilities in its growth strategy as it seeks to navigate a competitive landscape and achieve $750 million in cost savings.
“Cardinal Health, Inc. · scaled a new 52-week high · $62.15 · Apr 8”
“Cardinal Health, Inc. · closed the session marginally lower · $61.90”
“Cardinal Health, Inc. · gained · 1.7% · over the past year”
“Cardinal Health, Inc. · registered earnings gain · 2.2% · over the past five years”
“Cardinal Health, Inc. · has long-term expected growth rate · 4.6%”
“Cardinal Health, Inc. · surpassed the Zacks Consensus Estimate · in one of the trailing four quarters”
“Cardinal Health, Inc. · missed the Zacks Consensus Estimate · in three of the trailing four quarters”
“Cardinal Health, Inc. · is witnessing an upward trend in its stock price”
“Cardinal Health, Inc. · has a diversified product portfolio”
“Cardinal Health · announced its business · WaveMark Supply Management and Workflow Solutions · in November 2021”
“Cardinal Health · is boosting its core Medical and Pharmaceutical Distribution”
“Cardinal Health · is investing in its IT infrastructure”